AC Immune (ACIU) Payables (2014 - 2026)

AC Immune (ACIU) has reported Payables for 12 consecutive years, with $1.7 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Payables rose 63236.65% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (up 63236.65% YoY), while the FY2025 annual figure was $2.5 billion, up 82106.26% from the prior year.
• Payables fell to $1.7 billion in Q1 2026 per ACIU's latest filing, from $2.6 billion in the prior quarter.
• Across five years, Payables topped out at $2.6 billion in Q4 2025 and bottomed at $964322.4 in Q4 2022.
• Historically, Payables has averaged $416.6 million across 5 years, with a median of $2.7 million in 2025.
• Annual changes were most pronounced in 2022 — Payables sank 99.96% — and 2023, when it soared 196185.83%.
• AC Immune's Payables stood at $964322.4 in 2022, then surged by 196185.83% to $1.9 billion in 2023, then slumped by 99.84% to $3.0 million in 2024, then jumped by 85176.15% to $2.6 billion in 2025, then sank by 34.9% to $1.7 billion in 2026.
• Business Quant data shows ACIU's Payables at $1.7 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.0 million in Q3 2025.